COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Proteolytic control of the SARS-CoV-2 furin cleavage site defines the phenotypic evolution from the pandemic to endemic state
Aggarwal, A., Ognenovska, S., Ison, T., Fichter, C., Milogiannakis, V., Afzal, M., Ospina-Stella, A., Asarnow, D., Morgan, A. L., Waters, S., Boecking, T., Ng, B., Esneau, C., Bartlett, N., Naik, A., poehlmann, S., Hoffmann, M., Broer, S., Broer, A., Johansen, M. D., Brink, R., burrell, L. M., patel, S. K., Ellis, S., wehrhahn, M., Ginn, A., Martinez, E., Churchill, M. J., Angelovich, T. A., Rawlinson, W., Yeang, M., Walker, G., Foster, C., Kok, J., Sintchenko, V., Rocket, R., Asquith, W., Parry, R., Sng, J. D., Neely, G., Moreno, C., Spence, M., Jackson, C., Loo, L., Park, Y.-J., Gibson, C., Merz, B., Stewart, C., Kelleher, A. D., Brilot, F., Khromykh, A. A., Veesler, D., Menachery, V. D., Turville, S. G.
10.64898/2026.09.23.753140 — Posted: 2026-09-24
Predicting single mutation effects on binding affinity at protein-protein interfaces based on MMPBSA calculations
Noske, J., Janzen, M., Lepoivre, T., Höcker, B.
10.64898/2026.09.22.753561 — Posted: 2026-09-24
Deciphering Mechanistic Signatures in Drug-Drug Interactions with Dual Topology Graphs
Ma, W., Bi, X., Jiang, H., Lu, W., Nie, J., Lin, S., Lin, J., Wei, Z., Zhang, H., Zhang, S.
10.64898/2026.09.23.753684 — Posted: 2026-09-24
Detection and characterisation of alpha- and betacoronaviruses in rodents and bats from Germany, France, Belgium and Ireland
Sgarabotto, E., Venkat, V., Altan, E., Gyzels, D., Erdin, M., Lehtinen, V., Niamsap, T., Greilich, S., Valta, A., Galan, M., Firozpoor, J., Eccard, J. A., Jacob, J., Imholt, C., Sluydts, V., Colombo, V., Leirs, H., McManus, A., Stuart, P., Gryseels, S., De Bruyn, L., Voigt, C. C., Hoffmeister, U., Alburkat, H., Bourret, V., Smura, T., Castel, G., Charbonnel, N., Sironen, T., Dutra, L. A. L.
10.64898/2026.09.23.753110 — Posted: 2026-09-24
Early Steps in Pathogen-induced TTR-amyloid-formation
Premathilaka, M. B., Hansmann, U. H. E.
10.64898/2026.09.21.753243 — Posted: 2026-09-24
Multi-attribute characterisation of mRNA via MazF endoribonuclease and LC-MS workflows
Welbourne, E. P., Owen, G. R., Wright, L. P., Trabulo, S., Kis, Z., Dickman, M. J.
10.64898/2026.09.23.753728 — Posted: 2026-09-24
Mutational screening reveals a cluster of residues within the SARS-CoV-2 nsp1 N-terminus that confers RNA-targeting selectivity
Guillen, J. V., Tokamov, S. A., Glaunsinger, B. A.
10.64898/2026.09.22.753304 — Posted: 2026-09-23
A knockout screening platform for interferon-stimulated genes in respiratory cells identifies LY6E as a dominant antiviral effector against coronaviruses
Stoddard, C. I., Litchford, M. L., Sung, K., Hutcheson, R. L., Marceau, J., Johnson, T., Ota, A., Baumgarten, N. E., Gale, M., Overbaugh, J.
10.64898/2026.09.21.751853 — Posted: 2026-09-23
Bronchial epithelial IB3-1 cells exposed to the anti-SARS-CoV2 BNT162b2 vaccine: induction of apoptosis is partially reversed by Aged Garlic Extract (AGE) and its bioactive components S-allyl-Cysteine and S1-propenyl-l-Cysteine
di Padua, F., Marzaro, G., Agostinelli, E., Gambari, R., Finotti, A.
10.64898/2026.09.19.752820 — Posted: 2026-09-21
Localized SARS-CoV-2 Infection Triggers a Tissue-Wide Antiviral Response and Functional Impairment of Olfactory Sensory Neurons
Liu, J., Akhtar, M. S., Liu, H., Kim, Y., Ramirez, B. M., Weidner, A. L., Chan, A., Collins, M., Rothenburg, S., Coffey, L. L., Gong, Q.
10.64898/2026.09.19.752823 — Posted: 2026-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).